SHL Telemedicine closed acquisition of Jumedi GmbH a developer of Digital Health technologies and strengthens leadership of its German operation Montag, 25. Januar 2021 - 07:00

Press release

Mr. Linus Drop joins as Managing Director of SHL German Operation

Tel Aviv / Zurich, 25 January, 2021 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL” or the “Company”), a leading provider and developer of advanced personal telemedicine solutions, announced today that that its German subsidiary closed on the acquisition of 100% of Jumedi GmbH.

Following the closing, Mr. Linus Drop was nominated as Co-Managing Director of SHL German Operation, together with Mr. Ralf Bork. Mr. Drop has significant experience in the German Healthcare market. He founded Jumedi in 2017 and served as its Managing Director. From 2008 to 2017 he held the position of Managing Director of Sanvartis GmbH, a German telehealth company. Mr. Drop started his career at Barmer Healthcare Insurance company where he held different positions for over 10 years.

Jumedi GmbH is a developer of a modular system for digital health applications (DiGA) and of

“CareDoc” an innovative hybrid CRM system with integrated medical app, mainly being used by Healthcare Insurance companies in Germany. Jumedi GmbH was founded in 2017, employs about 20 people, mainly Software and IT Solutions developers, and about $ 3.5 million were invested in its operations since inception.

Further information

Martin Meier-Pfister, IRF, Phone: +41 43 244 81 40, shl@irf-reputation.ch

About SHL Telemedicine

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957). For more information, please visit our web site at www.shl-telemedicine.com.

Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.